FSP and COVID-19: Impact on Clinical Trial Development

July 17, 2020

The functional service provider (FSP) outsourcing model enables sponsors to efficiently and cost-effectively manage workforce needs across clinical portfolios. FSP models proved to be a strategic asset during the coronavirus pandemic when the ability to increase resource flexibility and provide targeted access to specific expertise became critical to clinical trial continuity.  

Previous Article
The future is now: Decentralized clinical trials during the pandemic and beyond
The future is now: Decentralized clinical trials during the pandemic and beyond

Enabling patients to participate in clinic trials from home is both important to maintain patient safety an...

Next Flipbook
COVID-19 and the new pragmatism
COVID-19 and the new pragmatism